A panel of U.S. Food and Drug Administration advisers on Wednesday unanimously voted in favor of approving Emergent BioSolutions Inc’s over-the-counter version of opioid overdose reversing drug Narcan. The favorable vote puts the treatment on track to potentially become the…

Read Full Article (External Site)